Abstract
Viral hemorrhagic fever has caused a worrying number of deaths in recent years, leading to some outbreaks being declared by the World Health Organisation as an international emergency.
Viral hemorrhagic fever in pregnancy is relevant as it affects not only the mother and the unborn baby, but it also has the potential of human-to-human transmission leading to large nosocomial outbreaks, affecting not just patients but healthcare providers looking after these patients.
It is important to understant the pathophysiology of the viruses and how the pregnant women and the unborn fetus cope with it. The management of this special population is crucial to ensure the well being of both mother and the fetus while maintaining safety of the healthcare provider as well. Treatment especially has to be titrated according to what would be safe for use in pregnant versus non-pregnant population.
The chapter discusses the four important viral hemorrhagic fevers—Ebola virus, Marburg, Lassa fever, and Yellow Fever.
This chapter also addresses the limitations of research of viral hemorrhagic fever in pregnancy which has increased over the years, however due to safety profiles and ethical legislations. Though such fevers have increased over the years, treatment and vaccines are unfortunately still lacking.
It overall highlights pregnant women being a population that has restrictions in practicing full evidence-based medicine and recruitment of trials, but healthcare providers are practicing as best as they can to provide the best care for pregnant women.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ftika L, Maltezou HC. Viral haemorrhagic fevers in healthcare settings. J Hosp Infect. 2013;83(3):185–92. ISSN 0195-6701, https://doi.org/10.1016/j.jhin.2012.10.013
Cobo F. Chapter 17 Viral haemorrhagic fevers. In: Imported infectious diseases. Elsevier; 2014.
Schnittler HJ, Feldmann H. Viral haemorrhagic fever—a vascular disease? Thromb Haemost. 2003;89:967–72.
Krubiner CB, Schwartz DA. Viral haemorrhagic fevers in pregnant women and the vaccine landscape: comparisons between yellow fever, Ebola, and Lassa fever. Curr Trop Med Rep. 2019;6:186–96. https://doi.org/10.1007/s40475-019-00194-x.
Silasi M, Cardenas I, Kwon J-Y, Racicot K, Also P, Mor G. Viral infections during pregnancy. Am J Reprod Immunol. 2015;73(3):199–213. https://doi.org/10.1111/aji.12355.
Beigi RH. Emerging infectious diseases in pregnancy. Obstet Gynaecol. 2017;129(5):896–906. https://doi.org/10.1097/aog.0000000000001978.
Paessler S, Walker DH. Pathogenesis of the viral haemorrhagic fevers. Annu Rev Pathol Mech Dis. 2013;8(1):411–40. https://doi.org/10.1146/annurev-pathol-020712-164041.
Buchanan SK, Coetzee AJ, Bishenden W, Mahomed Z, Laher AE. Managing viral haemorrhagic fever in the emergency department. J Clin Diagn Res. 2018;12(11):LE01–6. https://doi.org/10.7860/JCDR/2018/36305/12208.
WHO Ebola Response Team. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Eng J Med. 2014;371:1481–95.
Bebell LM, Oduyebo T, Riley LE. Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes. Birth Defects Res. 2017;109(5):353–62. https://doi.org/10.1002/bdra.23558.
Haddad LB, Jamieson DJ, Rasmussen SA. Pregnant women and the Ebola crisis. N Engl J Med. 2018;379(26):2492–3.
https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease
Fowler RA, Fletcher T, Fischer WA II, Lamontagne F, Jacob S, Brett-Major D, et al. Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med. 2014;190:733–7.
Bebell LM, Riley LE. Ebola virus disease and Marburg disease in pregnancy: a review and management considerations for filovirus infection. Obstet Gynaecol. 2015;125(6):1293–8. https://doi.org/10.1097/aog.0000000000000853.
Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola virus disease in West Africa—clinical manifestations and management. N Engl J Med. 2014;371:2054–7.
WHO Case definition recommendations for Ebola or Marburg virus diseases.
Fletcher T, Fowler RA, Beeching NJ. Understanding organ dysfunction in Ebola virus disease. Intensive Care Med. 2014;40:1936–9.
Black BO, Caluwaerts S, Achar J. Ebola viral disease and pregnancy. Obstet Med. 2015;8(3):108–13. https://doi.org/10.1177/1753495X15597354.
Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO. Annex 1.
Marzi A, Menicucci AR, Engelmann F, Callison J, Horne EJ, Feldmann F, Jankeel A, Feldmann H, Messaoudi I. Protection against Marburg virus using a recombinant VSV-vaccine depends on T and B cell activation. Front Immunol. 2019;9:3071. https://doi.org/10.3389/fimmu.2018.03071.
Legardy-Williams JK, Carter RJ, Goldstein ST, Jarrett OD, Szefer E, Fombah AE, et al. Pregnancy outcomes among women receiving rVSVΔ-ZEBOV-GP Ebola vaccine during the Sierra Leone Trial to introduce a vaccine against Ebola. Emerg Infect Dis. 2020;26(3):541–8. https://doi.org/10.3201/eid2603.191018.
https://www.who.int/news-room/fact-sheets/detail/yellow-fever
Monath TP, Vasconcelos PFC. Yellow fever. J Clin Virol. 2015;64:160–73. https://doi.org/10.1016/j.jcv.2014.08.030.
Bentlin MR, de Barros Almeida RA, Coelho KI, et al. Perinatal transmission of yellow fever, Brazil 2009. Emerg Infect Dis. 2011;17(9):1779–80. https://doi.org/10.3201/eid1709.110242.
Safety of immunization during pregnancy. A review of the evidence. https://www.who.int/vaccine_safety/publications/safety_pregnancy_nov2014.pdf
WHO. Ninth plenary meeting, 24 May 2014—Committee A, sixth report.
Price ME, Fisher-Hoch SP, Craven RB, McCormick JB. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. Br Med J. 1988;297:584.
Andersen KG, Sharpio BJ, Matranga CB, Sealfon R, Lin AE, Moses LM, et al. Viral Haemorrhagic Fever Consortium. Clinical sequencing uncovers origins and evolution of Lassa virus. Cell. 2015;162:738–50. https://doi.org/10.1016/j.cell.2015.07.020.
Kayem ND, Benson C, Aye CYL, Barker S, Tome M, Kennedy S, Ariana P, Horby P. Lassa fever in pregnancy: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2020;114(5):385–96. https://doi.org/10.1093/trstmh/traa011.
Merlin. Licking Lassa fever: a strategic review. London: Merlin; 2002.
Clinical management of patients with viral haemorrhagic fever. World Health Organization; 2014.
Chen JP, Cosgriff TM. Haemorrhagic fever virus-induced changes in haemostasis and vascular biology. Blood Coagul Fibrinolysis. 2000;11:461–83.
Brosh-Nissimov T. Lassa fever: another threat from West Africa. Disaster and Mil Med. 2016;2:8. https://doi.org/10.1186/s40696-016-0018-3.
Liao BS, Byl FM, Adour KK. Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: evidence of viral cause. Otolaryngol Head Neck Surg. 1992;106:226–9.
Okogbenin S, Okoeguale J, Akpede G, et al. Retrospective cohort study of Lassa fever in pregnancy, Southern Nigeria. Emerg Infect Dis. 2019;25(8):1494–500. https://doi.org/10.3201/eid2508.181299.
World Health Organisation. WHO Target product profile for Lassa virus vaccine. 2017.
Acknowledgment
Literature Search of Viral Haemorrhagic Fever in Pregnancy (October 2020), Birmingham UK, performed by Derick Yates, Birmingham Women’s and Children’s NHS Trust Library and Knowledge service.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Goh, E., Singh, R. (2022). Viral Hemorrhagic Fever. In: Mehta, S., Grover, A. (eds) Infections and Pregnancy. Springer, Singapore. https://doi.org/10.1007/978-981-16-7865-3_11
Download citation
DOI: https://doi.org/10.1007/978-981-16-7865-3_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-7864-6
Online ISBN: 978-981-16-7865-3
eBook Packages: MedicineMedicine (R0)